Analysis of sunitinib malate, a multi-targeted tyrosine kinase inhibitor: A critical review

被引:6
|
作者
AboulMagd, Asmaa M. [1 ]
Abdelwahab, Nada S. [1 ,2 ]
机构
[1] Nahda Univ NUB, Dept Pharmaceut Chem, Fac Pharm, Bani Suwayf, Egypt
[2] Beni Suef Univ, Dept Pharmaceut Analyt Chem, Fac Pharm, Bani Suwayf, Egypt
关键词
Analytical methods; Sunitinib malate; Multi-targeted tyrosine kinase inhibitor; Therapeutic drug monitoring; N-DESETHYL SUNITINIB; MICELLAR LIQUID-CHROMATOGRAPHY; ENDOTHELIAL GROWTH-FACTOR; LC-MS/MS METHOD; HUMAN PLASMA; ACTIVE METABOLITE; SIMULTANEOUS QUANTIFICATION; CAPILLARY-ELECTROPHORESIS; MULTIKINASE INHIBITOR; VALIDATION;
D O I
10.1016/j.microc.2021.105926
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Sunitinib malate is a multi-targeted tyrosine kinase inhibitor. This work presents a review of characteristics and analytical methods applied for its determination due to the impact of developing effective and reliable analytical methods for quality control analysis, therapeutic drug monitoring, pharmacokinetics, and bioavailability studies. Most of the published methods depended on LC/MS/MS; also ultraviolet spectrophotometric, chemiluminescence, electrochemical, capillary electrophoresis, high-performance thin-layer chromatography, and high-performance liquid chromatography methods were used for estimation of sunitinib. A discussion presented here highlighted the need for developing alternative methods that are money and time saving, need minimum sample pre-treatment steps, consume less toxic solvents, and hence have minimum residue. Also, the literature revealed a deficiency in studying possible drug-drug pharmacokinetic interactions.
引用
下载
收藏
页数:18
相关论文
共 50 条
  • [31] E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion
    Glen, Hilary
    Mason, Susan
    Patel, Hitesh
    Macleod, Kenneth
    Brunton, Valerie G.
    BMC CANCER, 2011, 11
  • [32] MEDI 301-ABT-869, an orally active multi-targeted receptor tyrosine kinase inhibitor
    Dai, Yujia
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [33] A Phase I Study of the Multi-Targeted Tyrosine Kinase Inhibitor Cabozantinib in Patients with Acute Myeloid Leukemia
    Fathi, Amir T.
    Blonquist, Traci M.
    Levis, Mark J.
    Hernandez, Daniela
    Ballen, Karen K.
    Avigan, David E.
    Joyce, Robin
    McMasters, Malgorzata
    Logan, Emma
    Hobbs, Gabriela S.
    Brunner, Andrew M.
    Connolly, Christine
    Perry, Ashley M.
    Joseph, Christelle
    Som, Tina T.
    Ramos, Aura Y.
    Neuberg, Donna S.
    Amrein, Philip C.
    BLOOD, 2016, 128 (22)
  • [34] Multi-targeted tyrosine kinase inhibitor Cabozantinib as a therapeutic agent in MET-overexpressing gastric cancer
    Choi, Audrey H.
    Lu, Jianming
    Lee, Sangjun
    Chu, Peiguo
    Chung, Vincent
    Lin, Ren-Jang
    Kim, Joseph
    Chao, Joseph
    CANCER RESEARCH, 2015, 75
  • [35] A phase II study of sunitinib, an oral multi-targeted tyrosine kinase inhibitor, in patients with unresectable, locally advanced or metastatic cervical carcinoma: IND184
    Mackay, H.
    Tinker, A.
    Winquist, E.
    Thomas, G.
    Sederias, J.
    Ivy, P.
    Eisenhauer, E. A.
    EJC SUPPLEMENTS, 2008, 6 (12): : 66 - 66
  • [36] Multi-targeted tyrosine kinase inhibitors and VEGFR-targeting agents
    Eckhardt, SG
    ANNALS OF ONCOLOGY, 2006, 17 : 20 - 20
  • [37] Profound Hair and Skin Hypopigmentation in an African American Woman Treated With the Multi-Targeted Tyrosine Kinase Inhibitor Pazopanib
    Sideras, Kostandinos
    Menefee, Michael E.
    Burton, Jill K.
    Erlichman, Charles
    Bible, Keith C.
    Ivy, S. Percy
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) : E312 - E313
  • [38] A lymphatic-absorbed multi-targeted kinase inhibitor for myelofibrosis therapy
    Ross, Brian D.
    Jang, Youngsoon
    Welton, Amanda
    Bonham, Christopher A.
    Palagama, Dilrukshika S. W.
    Heist, Kevin
    Boppisetti, Jagadish
    Imaduwage, Kasun P.
    Robison, Tanner
    King, Leah R.
    Zhang, Edward Z.
    Amirfazli, Cyrus
    Luker, Kathryn E.
    Lee, Winston Y.
    Luker, Gary D.
    Chenevert, Thomas L.
    Van Dort, Marcian E.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [39] The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication
    Martin Michaelis
    Christina Paulus
    Nadine Löschmann
    Stephanie Dauth
    Elisabeth Stange
    Hans Wilhelm Doerr
    Michael Nevels
    Jindrich Cinatl
    Cellular and Molecular Life Sciences, 2011, 68 : 1079 - 1090
  • [40] The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication
    Michaelis, Martin
    Paulus, Christina
    Loeschmann, Nadine
    Dauth, Stephanie
    Stange, Elisabeth
    Doerr, Hans Wilhelm
    Nevels, Michael
    Cinatl, Jindrich, Jr.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2011, 68 (06) : 1079 - 1090